FLORHAM PARK, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on […]
NOVATO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
Seasoned healthcare professional with over 20 years of strategic finance, capital markets and transactional/business-related expertise BEDMINSTER, N.J., Jan. 03, 2019 […]